Chemotherapy induces ace2 expression in breast cancer via the ros-akt-hif-1α signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy

HIGHLIGHTS

• who: Xiaoyan Zuo from the Public Laboratory, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin, China have published the Article: Chemotherapy induces ACE2 expression in breast cancer via the ROS-AKT-HIF-1u03b1 signaling pathway: a potential prognostic marker for breast cancer patients receiving chemotherapy, in the Journal: (JOURNAL) of 20/Oct/2022
• what: The authors investigated the relationship between ACE2 expression and treatment resistance and prognosis of breast cancer. Drugs used in this study are as follows: Epirubicin (EPI) was obtained from Hanhui Pharmaceuticals (Jiangsu, China). As illustrated . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.